During a unique symposium Monday afternoon chaired by Yehuda Handelsman, MD, four experts will be put on the spot when they’re asked to pick the best medication to prevent a cardiovascular event in a type 2 diabetes patient with established heart disease or at high risk for heart disease. Each panelist can advocate for only one treatment option.
Coming up: Unique session will require panelists to choose best medication for type 2 diabetes patient at risk of CV events
